Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

PTGXPTGX

Showing 8 of 31 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in PROTAGONIST THERAPEUTICS INC

Current Value

$778.2M

Current Shares

6.3M

Total Value Change

+$514.5M

Total Shares Change

+487,900

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
6.3M
0.0%
$778.2M3.6%$122.58
0
2026-Q1
Increased
6.3M
+3.3%
$669.2M3.5%$91.30
60
2025-Q4
Decreased
6.1M
-0.8%
$536.6M2.3%$87.26
0
2025-Q3
Increased
6.2M
+0.4%
$411.6M1.7%$65.14
49
2025-Q2
Increased
6.2M
+1.1%
$341.1M1.4%$55.69
49
2025-Q1
Increased
6.1M
+3.0%
$295.3M1.4%$48.88
50
2024-Q4
Increased
5.9M
+1.2%
$228.9M1.0%$38.51
49
2024-Q3
Increased
5.9M
+0.3%
$263.7M1.2%$44.56
49

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used